1. Home
  2. JKHY vs RPRX Comparison

JKHY vs RPRX Comparison

Compare JKHY & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JKHY
    SELLHOLDBUYas of a day ago
  • RPRX
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • JKHY 1976
  • RPRX 1996
  • Country
  • JKHY United States
  • RPRX United States
  • Employees
  • JKHY N/A
  • RPRX N/A
  • Industry
  • JKHY Retail: Computer Software & Peripheral Equipment
  • RPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JKHY Technology
  • RPRX Health Care
  • Exchange
  • JKHY Nasdaq
  • RPRX Nasdaq
  • Market Cap
  • JKHY 12.7B
  • RPRX 11.7B
  • IPO Year
  • JKHY N/A
  • RPRX 2020
  • Fundamental
  • Price
  • JKHY $174.75
  • RPRX $30.30
  • Analyst Decision
  • JKHY Hold
  • RPRX Strong Buy
  • Analyst Count
  • JKHY 12
  • RPRX 6
  • Target Price
  • JKHY $185.91
  • RPRX $41.67
  • AVG Volume (30 Days)
  • JKHY 552.6K
  • RPRX 3.8M
  • Earning Date
  • JKHY 02-04-2025
  • RPRX 02-13-2025
  • Dividend Yield
  • JKHY 1.58%
  • RPRX 2.76%
  • EPS Growth
  • JKHY 10.52
  • RPRX 518.56
  • EPS
  • JKHY 5.47
  • RPRX 2.55
  • Revenue
  • JKHY $2,245,157,000.00
  • RPRX $2,266,003,000.00
  • Revenue This Year
  • JKHY $9.18
  • RPRX $14.54
  • Revenue Next Year
  • JKHY $7.32
  • RPRX $10.94
  • P/E Ratio
  • JKHY $31.89
  • RPRX $11.88
  • Revenue Growth
  • JKHY 5.91
  • RPRX N/A
  • 52 Week Low
  • JKHY $157.00
  • RPRX $24.05
  • 52 Week High
  • JKHY $189.63
  • RPRX $31.66
  • Technical
  • Relative Strength Index (RSI)
  • JKHY 51.54
  • RPRX 75.65
  • Support Level
  • JKHY $169.49
  • RPRX $29.67
  • Resistance Level
  • JKHY $174.63
  • RPRX $31.09
  • Average True Range (ATR)
  • JKHY 2.94
  • RPRX 0.70
  • MACD
  • JKHY 0.11
  • RPRX 0.51
  • Stochastic Oscillator
  • JKHY 72.97
  • RPRX 86.63

Stock Price Comparison Chart: JKHY vs RPRX

JKHY
RPRX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160180200220JKHY VS RPRX

About JKHY Jack Henry & Associates Inc.

Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for us banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use